Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

NIOSHTIC-2 Publications Search

Search Results

Information Profile. Sodium Azide.

Authors
Gregory-AR
Source
NIOSH 1978 Jul:23 pages
Link
NIOSHTIC No.
00177552
Abstract
Sodium-azide (26628228) (NA) was described in terms of general properties and uses, toxicity, and occupational exposures. NA has been used in preparation of explosives, herbicides, photosensitive polymers, antibacterials, antidepressants, propellants, denitrification preventers, and for various organic syntheses. Hydrazoic-acid (7782798) (HA) has been used in preparation of inorganic, organic, and organometallic azides and derivatives. Some inorganic azides and HA were highly explosive. HA and NA were found to be strong hypotensive agents which dilate blood vessels by direct smooth muscle action. Azide stimulated cardiac muscle and dilated coronary vessels directly, and stimulated the central nervous system, causing increased respiratory and cardiac rate and force. Acute effects in animals included respiratory stimulation and violent tonic convulsions, causing respiratory depression and asphyxiation. Sublethal doses of NA and HA produced marked depression of blood pressure, coronary dilation, and mild respiratory stimulation with variable convulsions. Subchronic effects included temporary or permanent blindness without dilatation, incoordination, cerebellar ataxia, paresis or rigidity, fibrillary muscular tremors, and apathy. No carcinogenic effects were found for NA. Mutation studies of NA showed interference with cellular DNA repair and possible cocarcinogenesis. Less than 5000 workers were exposed per year, but there was a hazard in hospitals and laboratories where NA could react with plumbing and be explosive.
Keywords
NIOSH-Author; Laboratory-animals; Genetics; Pulmonary-system-disorders; Agricultural-chemicals; Explosives-industry; Pharmaceutical-industry; Nervous-system-disorders; Cardiovascular-system; Occupational-exposure; Toxic-effects; Explosive-hazards;
CAS No.
26628-22-8; 7782-79-8;
Publication Date
19780701
Fiscal Year
1978
NTIS Accession No.
PB88-188834
NTIS Price
A03
Priority Area
Asthma and Chronic Obstructive Pulmonary Disease; Disease and Injury; Pulmonary-system-disorders;
Source Name
DCDSD, NIOSH, 23 pages, 33 references
TOP